$2.39T
Total marketcap
$72.42B
Total volume
BTC 50.51%     ETH 15.00%
Dominance

Vaxil Bio Ltd. VXL.V Stock

0.02 CAD {{ price }} 50.000000% {{change_pct}}%
COUNTRY
Canada
Exchange
TSXV
Market Cap
2.05M CAD
LOW - HIGH [24H]
0.0100 - 0.02 CAD
VOLUME [24H]
49K CAD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.01 CAD

Vaxil Bio Ltd. Price Chart

Vaxil Bio Ltd. VXL.V Financial and Trading Overview

Vaxil Bio Ltd. stock price 0.02 CAD
Previous Close 0.02 CAD
Open 0.02 CAD
Bid 0.02 CAD x 0
Ask 0.02 CAD x 0
Day's Range 0.02 - 0.02 CAD
52 Week Range 0.01 - 0.04 CAD
Volume 22.5K CAD
Avg. Volume 27.05K CAD
Market Cap 2.05M CAD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.01 CAD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

VXL.V Valuation Measures

Enterprise Value 2.05M CAD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.8749999
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Vaxil Bio Ltd. Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -50.00000000000000000000000000000000%
S&P500 52-Week Change 20.43%
52 Week High 0.04 CAD
52 Week Low 0.01 CAD
50-Day Moving Average 0.02 CAD
200-Day Moving Average 0.02 CAD

VXL.V Share Statistics

Avg. Volume (3 month) 27.05K CAD
Avg. Daily Volume (10-Days) 11.86K CAD
Shares Outstanding 136.98M
Float N/A
Short Ratio 0.36
% Held by Insiders 8.16%
% Held by Institutions 0.014%
Shares Short 2.64K
Short % of Float N/A
Short % of Shares Outstanding 0%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:2

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -0.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 0.008

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Vaxil Bio Ltd.

Country Canada
State ON
City Toronto
Address 3400 One First Canadian Place
ZIP M5X 1A4
Phone N/A
Website https://www.vaxil-bio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment. The company was founded in 2006 and is headquartered in Toronto, Canada.

Q&A For Vaxil Bio Ltd. Stock

What is a current VXL.V stock price?

Vaxil Bio Ltd. VXL.V stock price today per share is 0.02 CAD.

How to purchase Vaxil Bio Ltd. stock?

You can buy VXL.V shares on the TSXV exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Vaxil Bio Ltd.?

The stock symbol or ticker of Vaxil Bio Ltd. is VXL.V.

Which industry does the Vaxil Bio Ltd. company belong to?

The Vaxil Bio Ltd. industry is Biotechnology.

How many shares does Vaxil Bio Ltd. have in circulation?

The max supply of Vaxil Bio Ltd. shares is 136.98M.

What is Vaxil Bio Ltd. Price to Earnings Ratio (PE Ratio)?

Vaxil Bio Ltd. PE Ratio is now.

What was Vaxil Bio Ltd. earnings per share over the trailing 12 months (TTM)?

Vaxil Bio Ltd. EPS is -0.01 CAD over the trailing 12 months.

Which sector does the Vaxil Bio Ltd. company belong to?

The Vaxil Bio Ltd. sector is Healthcare.